Revvity Inc (NYSE:RVTY)
$ 116.14 -0.09 (-0.08%) Market Cap: 14.13 Bil Enterprise Value: 16.22 Bil PE Ratio: 56.19 PB Ratio: 1.79 GF Score: 81/100

PerkinElmer Inc at Stifel Healthcare Conference Transcript

Nov 20, 2019 / 04:30PM GMT
Release Date Price: $90.52 (-0.72%)
Unidentified Analyst

We're happy to have PerkinElmer with us here today. Jamey Mock, who is the CFO. Lots of interesting things going on at the company. And I think we're just going to do this as Q&A style, right? I believe...

James M. Mock
PerkinElmer, Inc. - Senior VP & CFO

Sounds great.

Questions & Answers

Unidentified Analyst;James M. Mock

Maybe a good place to start would just be -- so there are a lot of things going on in both the diagnostics side of the house and then the non-diagnostics. I'd like to actually start with the new DAS business, if I could. That's a business that, over time, has had some cyclical elements to it. I think people looking at the macro data points are, a, trying to figure out what the world is going to look like next year; and B, trying to figure out which parts of businesses are going to do better or worse. Can you just start by talking about how DAS has evolved and where there might or might not be sensitivities relative to macro factors?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot